Our Businesses
Our Company
Share
Back to top
Global Public Health
-
As global temperatures continue to rise, so too does the incidence of this mosquito-borne virus. Learn the latest about this growing health threat and how Johnson & Johnson is working to combat it.
-
For World Neglected Tropical Diseases Day, check out a video highlighting the company's commitment to caring for children with these common infections across the globe.
-
As the International AIDS Conference kicks off, learn how a new tool will help give this group greater power to prevent HIV on a monthly basis.
-
For World Schizophrenia Day, learn about how one inspiring young man with the condition is thriving despite the challenges—and how Johnson & Johnson is helping him and others like him to find new ways to manage their mental illness.
-
Meet four students dedicated to removing the stigma of mental illness and increasing access to crucial treatments around the world—with the help of the Global Mental Health Scholarship Fund.
-
A relaunched Johnson & Johnson partnership will help ensure that many young patients get lifesaving access to HIV medicines. Meet a doctor in Kenya who explains why the program is so crucial.
-
Despite being preventable and curable, tuberculosis is one of the world’s deadliest infectious diseases—and COVID-19 is making it even harder to diagnose and treat it. Enter these healthcare visionaries, who've made it their mission to move the world closer to the goal of ending tuberculosis.
-
From churches to schools—and even roving healthcare vans—the company has rolled out a program in states across the nation to help get COVID-19 testing and other crucial health services to underserved communities.
-
A potential COVID-19 vaccine. Passionate efforts toward achieving racial and social justice. Smarter, more sustainable product packaging. These are just a few of the resolutions company change makers are aiming to bring to light this year—and they're already hard at work on them.
-
It's one of the world's deadliest infectious diseases, killing more people each year than HIV/AIDS and malaria combined. We're taking a look back at the strides the company has made in fighting this preventable illness to help bring us closer to a tuberculosis-free world.
-
Imagine getting so sick from a preventable disease that you can't play or attend school—multiple times a year. For World Children's Day, we're sharing the story of Sheti and others just like her who now have a chance to take back their childhoods, thanks to a new formulation of a medication to treat intestinal worms.
-
In response to a new Ebola outbreak in Guinea, Johnson & Johnson is providing up to 200,000 doses of its Ebola vaccine regimen to the country for a World Health Organization supported clinical trial. Learn more about the initiative and other top facts about the vaccine regimen for the deadly virus.
-
Doctors, nurses and other healthcare professionals are working tirelessly to treat patients infected with the novel coronavirus. To bolster their heroic efforts, the company committed $50 million to help organizations dedicated to helping them.
-
Roland Zahn, Ph.D., a Janssen scientist and expert in viral vaccines, was at the front lines of research during the Ebola outbreak. Today he and his team are working at record speed to help deliver a potential vaccine for the novel coronavirus.
-
Chairman & CEO Alex Gorsky shares that the company could have the first batches of a COVID-19 vaccine available for emergency-use authorization in early 2021—a substantially accelerated time frame in comparison to the typical vaccine development process.
